AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimismart MF 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Genuwin Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimismart MF 2mg/500mg Tablet SR

Diabex Duo 2mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined individually by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by symptoms such as sweating, lightheadedness, headache, and tremors. Learn to recognize and manage these symptoms. Maintaining regular meals and carrying a quick-acting glucose source (e.g., sugary snacks or juice) is vital. Alcohol consumption elevates hypoglycemia risk and should be minimized. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment, as suitability may be affected. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Uses of Glimismart MF 2mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Glimismart MF 2mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the Glimismart MF 2mg/500mg Tablet SR whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glimismart MF 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimismart MF 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Take Glimismart MF 2mg/500mg Sustained-Release tablets with a meal.

How Glimismart MF 2mg/500mg Tablet SR works:

Glimismart MF SR tablets (2mg/500mg) combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimismart MF 2mg/500mg SR tablets with alcohol is not recommended due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimismart MF 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimismart MF 2mg/500mg tablets are contraindicated during lactation due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Exercise caution when prescribing Glimismart MF 2mg/500mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Severe kidney disease contraindicates the use of Glimismart MF 2mg/500mg SR tablets. Physician consultation is recommended. Close monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing Glimismart MF 2mg/500mg Tablet SR to individuals with hepatic impairment; dosage modification may be necessary. Medical consultation is advised. For patients exhibiting mild to moderate liver disease, initiate treatment with a reduced Glimismart MF 2mg/500mg Tablet SR dosage; the medication is contraindicated in cases of severe liver dysfunction.

What if you forget to take Glimismart MF 2mg/500mg Tablet SR :

Should you forget a Glimismart MF 2mg/500mg SR Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glimismart MF 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimismart MF 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Glimismart MF 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. Seek immediate medical attention, including discontinuing Glimismart MF 2mg/500mg Tablet SR, if these symptoms occur.
Glimismart MF 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes. This combination improves blood sugar control in adults when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is unsuitable for type 1 diabetes.
Glimismart MF 2mg/500mg Tablet SR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimismart MF 2mg/500mg Tablet SR can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental Vitamin B12 is recommended by some researchers.
Glimismart MF 2mg/500mg Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimismart MF 2mg/500mg Tablet SR with alcohol is unsafe. Alcohol can lower blood sugar, potentially causing hypoglycemia, and increase the risk of lactic acidosis.
Glimismart MF 2mg/500mg T...
70
MRP 86
18% off